Who are the top shareholders of the Balaji Phos.?

The top shareholders of Balaji Phos. include promoter Mohit Airen with 27.67%, three foreign institutional investors with a combined 3.55%, and public shareholder Astorne Capital Vcc - Alpha A2 with 2.34%. Individual investors hold 10.3%, with no pledged promoter holdings or mutual funds invested.

The top shareholders of Balaji Phos. include the promoters, who hold the majority of the shares. The promoter with the highest holding is Mohit Airen, owning 27.67% of the company. Additionally, there are three foreign institutional investors (FIIs) holding a combined 3.55%. The highest public shareholder is Astorne Capital Vcc - Alpha A2, which holds 2.34%. Individual investors collectively hold 10.3% of the shares. There are no pledged promoter holdings and no mutual funds currently invested in the company.

When is the next results date for Balaji Phos.?

No Upcoming Board Meetings

Has Balaji Phos. declared dividend?

No Dividend History Available

Who are the peers of the Balaji Phos.?

Balaji Phos. peers include Nova Agritech, Rama Phosphates, Aries Agro, and others, with varying management risks and growth rates. Rama Phosphates leads in 1-year returns at 51.85%, while Balaji Phos. lacks available return data.

Peers: The peers of Balaji Phos. are Nova Agritech, Rama Phosphates, Aries Agro, Nagarjuna Fert., Dollex Agrotech, Sikko Industries, Bharat Agri Fert, Basant Agro Tech, and Indogulf Cropsci.<BR><BR>Quality Snapshot: Excellent management risk is observed at Rama Phosphates, while Good management risk is found at Balaji Phos. Average management risk is present at Nova Agritech, Aries Agro, Sikko Industries, and the rest. Below Average management risk is seen at Nagarjuna Fert., Dollex Agrotech, Bharat Agri Fert, and Basant Agro Tech. Growth is Below Average for Balaji Phos., Nova Agritech, Rama Phosphates, Aries Agro, Nagarjuna Fert., Sikko Industries, Bharat Agri Fert, Basant Agro Tech, and the rest, while Dollex Agrotech shows Good growth. Indogulf Cropsci does not qualify in any category.<BR><BR>Return Snapshot: Rama Phosphates has the highest 1-year return at 51.85%, while Nagarjuna Fert. has the lowest at -47.61%. Balaji Phos. does not have a 1-year return available for comparison. Additionally, Nagarjuna Fert. has a negative six-month return of -30.11%.

What does Balaji Phos. do?

Balaji Phosphates Ltd is a micro-cap company in the fertilizers industry, incorporated in 1996 and currently led by promoters Mohit Airen and Alok Gupta since 2014. It has a market cap of INR 332 Cr, with no recent sales or profit data reported.

Overview:<BR>Balaji Phosphates Ltd operates in the fertilizers industry and is categorized as a micro-cap company.<BR><BR>History:<BR>The company was originally incorporated as Balaji Phosphates Private Limited on April 4, 1996. Control of the company was transferred to its current promoters, Mr. Mohit Airen and Mr. Alok Gupta, in 2014. There is no recent sales and profit data reported.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: N/A<BR>Most recent Net Profit: N/A<BR>Market-cap value: INR 332 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: 42.00<BR>Industry P/E: 24<BR>Dividend Yield: 0.00%<BR>Debt-Equity: 0.89<BR>Return on Equity: 22.63%<BR>Price-to-Book: 9.58<BR><BR>Contact Details:<BR>Registrar Address: Not available.

How big is Balaji Phos.?

As of 23rd July, Balaji Phosphates Ltd has a market capitalization of 337.00 Cr, classifying it as a Micro Cap company, with no available financial data for Net Sales and Net Profit for the latest four quarters. The balance sheet as of March 2024 shows Shareholder's Funds of 35.00 Cr and Total Assets of 88.48 Cr.

As of 23rd July, <BR><BR>Market Cap: Balaji Phosphates Ltd has a market capitalization of 337.00 Cr, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for Net Sales and Net Profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2024, with Shareholder's Funds amounting to 35.00 Cr and Total Assets valued at 88.48 Cr.

Is Balaji Phos. overvalued or undervalued?

As of August 28, 2025, Balaji Phosphates is considered very expensive with a PE ratio of 52.55 and significantly higher valuation metrics compared to peers, indicating it is overvalued despite a recent 27.79% stock return.

As of 28 August 2025, the valuation grade for Balaji Phosphates has moved from expensive to very expensive, indicating a significant increase in perceived valuation. The company is currently overvalued, with a PE ratio of 52.55, a Price to Book Value of 11.89, and an EV to EBITDA ratio of 33.70. These ratios suggest that the stock is trading at a premium compared to its earnings and book value.<BR><BR>In comparison to its peers, Balaji Phos. stands out with a much higher PE ratio than Coromandel International, which has a PE of 33.60, and significantly exceeds Chambal Fertilizers, which is valued at 12.41. The PEG ratio of Balaji Phos. is notably 0.00, indicating no growth expectations priced into the stock, contrasting sharply with peers like Coromandel, which has a PEG of 0.93. Despite recent stock performance showing a 27.79% return over the past month compared to a -0.73% return for the Sensex, the overall valuation metrics suggest that Balaji Phos. is not justified at its current price level.

How has been the historical performance of Balaji Phos.?

Balaji Phos. experienced a decline in net sales from 151.55 Cr to 126.52 Cr in the fiscal year ending March 2025, but profitability metrics improved, with profit after tax rising to 7.92 Cr and operating profit margin increasing to 10.49%. Total assets also grew significantly, despite negative cash flow from operating activities.

Answer:<BR>The historical performance of Balaji Phos. shows a mixed trend in financial metrics over the past year.<BR><BR>Breakdown:<BR>In the fiscal year ending March 2025, Balaji Phos. reported net sales of 126.52 Cr, a decrease from 151.55 Cr in March 2024. The total operating income mirrored this decline, remaining at 126.52 Cr, while total expenditure decreased to 113.25 Cr from 139.45 Cr. Operating profit, excluding other income, improved to 13.27 Cr from 12.10 Cr, and the overall operating profit rose to 15.32 Cr from 12.23 Cr. Profit before tax increased to 10.64 Cr from 8.37 Cr, leading to a profit after tax of 7.92 Cr, up from 6.04 Cr the previous year. The earnings per share slightly decreased to 3.33 from 3.39, while the diluted earnings per share increased to 4.34. The operating profit margin improved to 10.49% from 7.98%, and the profit after tax margin rose to 6.26% from 3.99%. On the balance sheet, total assets increased to 124.35 Cr from 88.48 Cr, with total liabilities also rising to 124.35 Cr from 88.48 Cr. The book value per share saw a significant increase to 33.66 from 19.62. Cash flow from operating activities turned negative at -36.00 Cr, while cash flow from financing activities improved to 31.00 Cr from 3.00 Cr. Overall, while sales showed a decline, profitability metrics and asset values demonstrated positive trends.

Which are the latest news on Balaji Phos.?

Why is Balaji Phos. falling/rising?

As of 04-Dec, Balaji Phosphates Ltd's stock price is at 118.50, down 1.25%, and underperforming its sector. Despite a significant increase in delivery volume, the stock is trading below all key moving averages, indicating a bearish trend and cautious investor sentiment.

As of 04-Dec, Balaji Phosphates Ltd's stock price is falling, currently at 118.50, which reflects a decrease of 1.5 or 1.25%. The stock has underperformed its sector by 0.82% today and is trading lower than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. Despite a significant increase in delivery volume, which rose by 367.74% against the 5-day average, the overall performance suggests that investor sentiment may be cautious. Additionally, while the stock has shown a positive return of 1.72% over the past week, it has not been able to maintain momentum compared to the broader market, as evidenced by the Sensex's decline of 0.69% during the same period.